NFE2L2 and T-cell acute lymphoblastic leukemia: Previous studies have reported that dimethyl fumarate (DMF), an Nrf2 activator, induces the protein expression of both Nrf2 and HACE1 in a dose-dependent manner, thereby inhibiting the proliferation of T-cell acute lymphoblastic leukemia cells (19).